## USER 🧑‍💻

<session_context>
This is the Gemini CLI. We are setting up the context for our chat.
Today's date is Thursday, April 23, 2026 (formatted according to the user's locale).
My operating system is: linux
The project's temporary directory is: /home/ericbell/.gemini/tmp/amethystb-0002-5
- **Workspace Directories:**
  - /home/ericbell/workspaces/dataannotation/AmethystB-0002.5
- **Directory Structure:**

Showing up to 200 items (files + folders). Folders or files indicated with ... contain more items not shown, were ignored, or the display limit (200 items) was reached.

/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/
├───.gitignore
├───.python-version
├───0 - Conversation.md
├───1 - Task Description.md
├───2 - Prompt.md
├───260212 Encounter notes.md
├───260422 Office visit Healthcare statement redacted.pdf
├───260422.DataEntry.md
├───260422.Instructions.md
├───3 - Expected output.md
├───amethyst-files.zip
├───main.py
├───notes
├───pyproject.toml
├───README.md
├───transcript01.md
└───.git/...


</session_context>

---

## USER 🧑‍💻

Here is the user's editor context as a JSON object. This is for your information only.
```json
{
  "activeFile": {
    "path": "/home/ericbell/workspaces/dataannotation/AmethystB-0002.5/2 - Prompt.md",
    "cursor": {
      "line": 14,
      "character": 263
    },
    "selectedText": "Act as a Certified Professional Medical Auditor (CPMA). I have provided a clinical encounter note (\"260212 Encounter notes.md\") and the corresponding billing statement (\"260422 Office visit Healthcare statement redacted.pdf\") from a February 2026 office visit for a senior male patient.\n\nPlease perform a technical compliance audit of the billed charges—specifically CPT 99214 and HCPCS G2211—using the 2021-2025 CMS Evaluation and Management (E/M) Documentation Guidelines.\n\nProvide a formal Audit Findings Report as your deliverable. Your report must include the following sections:\n\n1. Medical Decision Making (MDM) Analysis: Independently score and provide your clinical rationale for each of the three required MDM elements:\n   - Number and Complexity of Problems Addressed\n   - Amount and/or Complexity of Data to be Reviewed and Analyzed\n   - Risk of Complications and/or Morbidity or Mortality of Patient Management\n\n2. E/M Level Determination: Based on your MDM analysis, state whether the documentation supports the billed CPT 99214. Provide a definitive recommendation to either uphold the billed code or downcode it to the appropriate supported level.\n\n3. HCPCS G2211 Compliance: Evaluate the G2211 complex visit add-on charge. State your conclusion on whether the encounter documentation successfully satisfies Medicare's specific reporting requirements for this add-on code, and provide your supporting rationale."
  }
}
```

---

## USER 🧑‍💻

Act as a Certified Professional Medical Auditor (CPMA). I have provided a clinical encounter note ("260212 Encounter notes.md") and the corresponding billing statement ("260422 Office visit Healthcare statement redacted.pdf") from a February 2026 office visit for a senior male patient.

Please perform a technical compliance audit of the billed charges—specifically CPT 99214 and HCPCS G2211—using the 2021-2025 CMS Evaluation and Management (E/M) Documentation Guidelines.

Provide a formal Audit Findings Report as your deliverable. Your report must include the following sections:

1. Medical Decision Making (MDM) Analysis: Independently score and provide your clinical rationale for each of the three required MDM elements:
   - Number and Complexity of Problems Addressed
   - Amount and/or Complexity of Data to be Reviewed and Analyzed
   - Risk of Complications and/or Morbidity or Mortality of Patient Management

2. E/M Level Determination: Based on your MDM analysis, state whether the documentation supports the billed CPT 99214. Provide a definitive recommendation to either uphold the billed code or downcode it to the appropriate supported level.

3. HCPCS G2211 Compliance: Evaluate the G2211 complex visit add-on charge. State your conclusion on whether the encounter documentation successfully satisfies Medicare's specific reporting requirements for this add-on code, and provide your supporting rationale.

---

## MODEL ✨

**Tool Command**:
```json
{
  "name": "read_file",
  "args": {
    "file_path": "260212 Encounter notes.md"
  },
  "id": "78zxemyh"
}
```

---

## USER 🧑‍💻

**Tool Response**:
```json
{
  "id": "78zxemyh",
  "name": "read_file",
  "response": {
    "output": "I understand. You need a faithful, line-by-line reproduction of the original document provided, maintaining the structure and specific phrasing while strictly masking all **Personally Identifiable Information (PII)** and **Protected Health Information (PHI)**.\n\nBelow is the redacted version of the document, including the header information and full narrative notes.\n\n---\n\n### [REDACTED] Chart - Past Visit Details\n**Name:** [REDACTED] | **DOB:** [REDACTED] | **MRN:** [REDACTED] | **PCP:** [REDACTED], MD | [cite_start]**Legal Name:** [REDACTED] [cite: 3]\n[cite_start]**Office Visit - Feb 12, 2026** [cite: 4]\n[cite_start]**with [REDACTED], MD at [REDACTED] Physicians Primary Care, [REDACTED]** [cite: 5]\n\n---\n\n#### [cite_start]Notes from Care Team [cite: 6]\n[cite_start]**Daily Progress Notes by [REDACTED], MD at 2/12/2026 11:00 AM** [cite: 7]\n[cite_start]**Patient ID:** [REDACTED] is a 66 y.o. male. [cite: 8]\n\n[cite_start]**HPI** [cite: 9]\n1. [cite_start]**Controlled substance prescription renewal** [cite: 10]\n[cite_start]This visit is a check-in regarding a new prescription for a controlled substance. [cite: 11] [cite_start]He reports taking it for anxiety, particularly at nighttime when his mind races and he reflects on his past. [cite: 12] [cite_start]He describes these experiences as \"the ghosts of your past\" coming to visit. [cite: 13] [cite_start]He finds the anxiety awful at times. [cite: 13] [cite_start]He has taken the medication twice in the past week, which is unusual for him as he can go long periods without it. [cite: 14] [cite_start]He reports appropriate use of the medication, taking it as needed to \"quiet my mind down.\" [cite: 15] [cite_start]The prescription has been sent to the pharmacy for use at bedtime as needed. [cite: 16]\n\n2. [cite_start]**Shoulder pain** [cite: 17]\n[cite_start]Reports a history of a shoulder problem for which he has received physical therapy on two separate occasions. [cite: 18] [cite_start]He is now completely pain-free for the first time in years. [cite: 19] [cite_start]This resolution of pain started approximately six months ago. [cite: 19] [cite_start]He now has a full range of motion without any pain. [cite: 20] [cite_start]He can reach back to his side table while in bed, an action that previously always caused pain but now does not hurt at all. [cite: 21]\n\n3. [cite_start]**Morton's neuroma and new numbness** [cite: 22]\n[cite_start]He was previously diagnosed with a Morton's neuroma by a podiatrist. [cite: 23] [cite_start]He continues to wear insoles for this condition, and this has not changed. [cite: 24] [cite_start]In the last couple of weeks, he has developed a new area of numbness on his foot. [cite: 25] [cite_start]He describes it as not a profound numbness, as he can still feel touch, but the sensation is different. [cite: 26] [cite_start]He speculates it may be a pinched nerve. [cite: 27] [cite_start]He does not feel it is a threatening issue. [cite: 27]\n\n4. [cite_start]**GERD** [cite: 28]\n[cite_start]Reports ongoing issues with GERD. [cite: 29] [cite_start]He feels that this condition is under control. [cite: 29]\n\n5. [cite_start]**General stiffness and aging** [cite: 30]\n[cite_start]He is 67 years old. [cite: 34] [cite_start]He notes increased stiffness and difficulty with mobility, such as getting up from the floor or a couch after sitting for a while. [cite: 34] [cite_start]He reports making noises upon exertion, similar to his father. [cite: 35]\n\n6. [cite_start]**Weight management** [cite: 36]\n[cite_start]He is actively working on weight management. [cite: 37] [cite_start]He reports his current weight is 216-217 lbs, which is an improvement from previous years. [cite: 37] [cite_start]His goal is to reach approximately 200 lbs while maintaining muscle mass. [cite: 38]\n\n7. [cite_start]**Exercise** [cite: 39]\n[cite_start]He reports doing \"virtually nothing\" for routine exercise, especially due to the weather. [cite: 40] [cite_start]However, he engages in physically demanding activities around the house and yard, such as snow blowing a large area (deck, front walkway, 75-foot driveway, and a $25 \\times 25$ paddock). [cite: 41] [cite_start]He is mindful to engage his core muscles to stabilize his body and prevent injury. [cite: 42] [cite_start]He describes his pace during these activities and errands like grocery shopping as fast and purposeful. [cite: 43] [cite_start]He experiences some muscle soreness in his back afterward, which is expected given the sporadic nature of the intense activity. [cite: 44] [cite_start]This soreness resolves with a single dose of ibuprofen. [cite: 45]\n\n8. [cite_start]**Anxiety and sleep** [cite: 46]\n[cite_start]He experiences anxiety, particularly at night, which can interfere with his sleep. [cite: 47] [cite_start]Last night, he took ibuprofen for body aches and had a great night's sleep. [cite: 48] [cite_start]He notes that the night before, he only slept for four hours. [cite: 49] [cite_start]He is generally reluctant to take medication unless his body hurts. [cite: 50] [cite_start]He experienced a brief moment of word-finding difficulty when trying to recall the name \"ibuprofen,\" which caused him some concern about age-related cognitive changes, but he was able to recall the name on his own. [cite: 51]\n\n9. [cite_start]**Lower back pain** [cite: 52]\n[cite_start]He has a history of significant back issues dating back 20-30 years. [cite: 53] [cite_start]He believes the nerves have \"deaden[ed] out\" over time, as a psychiatrist had previously suggested might happen, leading to a reduction in pain signals to the brain. [cite: 54] [cite_start]In the past few weeks, he has experienced a recurrence of some of the earliest onset symptoms. [cite: 55] [cite_start]While not frequent, it has happened a few times. [cite: 56] [cite_start]This has prompted him to consider reconnecting with the spine specialists he saw previously in [REDACTED], who had successfully helped him manage his condition and steered him away from surgery. [cite: 56] [cite_start]He recalls the admonition at that time was that discectomies had a 30% success rate and that scar tissue could worsen the outcome. [cite: 57] [cite_start]He feels it is a good idea to check in with them again. [cite: 58] [cite_start]He recalls his previous physician was Dr. [REDACTED], who was enormously helpful. [cite: 59] [cite_start]He described prior episodes of severe back pain that constricted his diaphragm and caused labored breathing, which was a frightening experience. [cite: 60]\n\n---\n\n[cite_start]**Past Medical History:** [cite: 63]\n* [cite_start]Hypertension [cite: 63]\n* [cite_start]Sleep apnea [cite: 63]\n\n[cite_start]**Social History** [cite: 64]\n* [cite_start]Reports that he has quit smoking. [cite: 66]\n* [cite_start]Reports that he does not drink alcohol and does not use drugs. [cite: 67]\n\n[cite_start]**Family History** [cite: 68]\n* Asthma in mother; Bleeding disorder in mother; Blood disorder in mother; [cite_start]Cancer in mother. [cite: 69, 70]\n* [cite_start]Dementia in paternal grandmother. [cite: 70]\n* [cite_start]Hypertension in father, mother, and other family member. [cite: 70, 71]\n\n[cite_start]**Surgical History** [cite: 72]\n* [cite_start]Cardiac electrophysiology procedure ([REDACTED], 9/12/2022). [cite: 73]\n\n[cite_start]**Medication List** [cite: 76]\n* [cite_start]acyclovir 400 MG tablet (ZOVIRAX) [cite: 80, 81]\n* [cite_start]coenzyme Q10 50 mg capsule [cite: 86]\n* [cite_start]lansoprazole 30 MG capsule (PREVACID) [cite: 87, 88]\n* [cite_start]metoprolol ER 25 MG 24 hr tablet (TOPROL-XL) [cite: 90, 91]\n* [cite_start]Moringa oleifera 500 mg Cap [cite: 93]\n\n[cite_start]**Vital Signs (2/12/2026 11:11 AM)** [cite: 106]\n* [cite_start]**Heart Rate:** 63 [cite: 113]\n* **Weight:** 223! (LB) [cite_start][cite: 114]\n* [cite_start]**BMI:** 32.1 [cite: 101]\n* [cite_start]**SpO2:** 98% [cite: 121]\n* [cite_start]**Blood Pressure:** 120/84 [cite: 121, 122]\n\n---\n\n[cite_start]**Assessment & Plan:** [cite: 128]\n1. [cite_start]**Anxiety** [cite: 129]\n    * [cite_start]Assessment: Likely diagnosis for Issue 1: Anxiety. [cite: 130]\n    * [cite_start]Treatment: New prescription for a controlled substance sent to pharmacy. [cite: 134] [cite_start]To be taken at bedtime as needed for anxiety and to aid sleep. [cite: 135]\n2. [cite_start]**Chronic Shoulder Pain** [cite: 136]\n    * [cite_start]Assessment: Resolved chronic shoulder pain. [cite: 137]\n    * Treatment: Continued observation. [cite_start]No active treatment needed. [cite: 137, 138]\n3. [cite_start]**Morton's Neuroma and New-onset Numbness** [cite: 139]\n    * [cite_start]Assessment: Morton's neuroma, new-onset peripheral neuropathy. [cite: 140]\n    * Treatment: Continue wearing insoles. [cite_start]Monitor new symptoms. [cite: 141]\n4. [cite_start]**GERD** [cite: 142]\n    * [cite_start]Assessment: GERD, stable. [cite: 143]\n    * [cite_start]Treatment: Continue current management. [cite: 144]\n5. [cite_start]**Lower Back Pain** [cite: 145]\n    * [cite_start]Assessment: Chronic lower back pain with recent exacerbation. [cite: 146]\n    * [cite_start]Referrals: Plans to self-refer back to previous spine specialist. [cite: 147] [cite_start]Discussed that with current Medicare plan, he can self-refer without issue. [cite: 148]\n\n[cite_start]**Diagnoses and all orders for this visit:** [cite: 149]\n* [cite_start]**Panic attacks** [cite: 150]\n* [cite_start]**ALPRAZolam (XANAX) 0.5 MG tablet;** Take 1 tablet at bedtime as needed for insomnia or anxiety. [cite: 151]"
  }
}
```

---

## MODEL ✨

**Tool Command**:
```json
{
  "name": "read_file",
  "args": {
    "file_path": "260422 Office visit Healthcare statement redacted.pdf"
  },
  "id": "pdywcn79"
}
```

---

## USER 🧑‍💻

**Tool Response**:
```json
{
  "id": "pdywcn79",
  "name": "read_file",
  "response": {
    "output": "Binary content provided (1 item(s))."
  }
}
```

---

## MODEL ✨

Based on the 2021-2025 CMS Evaluation and Management (E/M) Documentation Guidelines, here is the formal Audit Findings Report for the clinical encounter and billing statement provided.

### **Audit Findings Report**

#### **1. Medical Decision Making (MDM) Analysis**

**Number and Complexity of Problems Addressed**
* **Score:** Moderate 
* **Clinical Rationale:** The provider evaluated and managed multiple medical conditions during the encounter. The documentation notes a recurrence of severe lower back pain ("recurrence of some of the earliest onset symptoms"), which qualifies as **one (1) chronic illness with exacerbation**. Furthermore, the provider assessed multiple stable chronic illnesses, including anxiety, gastroesophageal reflux disease (GERD), and Morton's neuroma. Either the presence of one chronic illness with exacerbation or two or more stable chronic illnesses is sufficient to meet the threshold for "Moderate" complexity in this category.

**Amount and/or Complexity of Data to be Reviewed and Analyzed**
* **Score:** Minimal / None
* **Clinical Rationale:** The encounter note does not document any orders for or review of laboratory tests, imaging, or other diagnostic studies. Additionally, there is no documented review of external medical records, independent interpretation of tests, or use of an independent historian. Therefore, the data element scores as minimal.

**Risk of Complications and/or Morbidity or Mortality of Patient Management**
* **Score:** Moderate
* **Clinical Rationale:** The provider engaged in explicit **prescription drug management**. The assessment and plan show the provider evaluated the patient's anxiety/panic attacks and prescribed/renewed a controlled substance (Alprazolam 0.5 mg). Deciding to prescribe or continue a systemic medication—particularly a controlled substance carrying risks of dependency and adverse central nervous system effects—firmly establishes a "Moderate" level of patient management risk.

---

#### **2. E/M Level Determination**

* **Determination:** **Uphold the billed CPT 99214.**
* **Rationale:** To establish an overall MDM level under the CMS E/M guidelines, at least two of the three MDM elements must meet or exceed the target level. In this encounter:
  1. Problems Addressed = *Moderate*
  2. Data Reviewed = *Minimal/None*
  3. Risk = *Moderate*
  
  Because two of the three elements reach the "Moderate" tier, the overall Medical Decision Making is Moderate. A moderate level of MDM for an established patient visit correctly satisfies the requirements to support the billed code **CPT 99214**. No downcoding is necessary. 

---

#### **3. HCPCS G2211 Compliance**

* **Conclusion:** **The documentation successfully supports the billed HCPCS G2211 add-on code.**
* **Rationale:** The HCPCS G2211 code is designated for the complexity inherent to E/M services when a provider serves as the *continuing focal point for all needed health care services* (longitudinal primary care) or manages a patient's single, serious, or complex condition on an ongoing basis. 

  The documentation demonstrates a comprehensive primary care relationship ("Primary Care" is established in the header context). Throughout the visit, the provider holistically evaluated multiple body systems and chronic conditions (anxiety, chronic back and shoulder pain, GERD, and neuropathy), addressed medication tolerance, discussed long-term weight management goals, and coordinated future specialty care (spine specialist referral). This broad, ongoing, and continuous management of the patient's overall health profile perfectly aligns with Medicare's intent for G2211. Furthermore, there are no minor procedures appended with a Modifier 25 billed on this date of service, which would otherwise preclude the reporting of G2211.